Eucker Group

Charité-Universitätsmedizin Berlin
Campus Benjamin Franklin
Tibor-Diamantstein-Haus, Haus IB
Hindenburgdamm 30
12203 Berlin

Sie befinden sich hier:

Eucker Group

Focus of research

  • Investigating the influence of JAK inhibitors on the Cytokine/JAK/STAT3 signaling pathway
  • Analysing the function of Bruton’s kinase
  • In-vitro screening of Bromodomain inhibitors
  • Overcoming chemotherapy resistance in tumor stem cells by Metformin

Group Leader

PD Dr. med. Jan Eucker

Leiter der Onkologie

CBF: Campus Benjamin Franklin

The Eucker group is focussing on investigation of malignant molecular and biochemical mechanisms  in breast cancer cell lines. A special focus lies on revealing new therapeutic approaches by dissecting the underlying pathways. Using cell culture models and tumor cells, innovative drugs as well as drug combinations are studied. Moreover, we analyse clinical outcome data of breast cancer patients from our own clinic for quality inspection and further development of therapeutic strategies.